SaltX Technology Holding B Logo

SaltX Technology Holding B

Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.

SALT | ST

Overview

Corporate Details

ISIN(s):
SE0005308541 (+1 more)
LEI:
549300W31010S0FY9U64
Country:
Sweden
Address:
Västertorpsvägen 135, 129 44 Hägersten
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SaltX Technology is a greentech company dedicated to decarbonizing heavy industries and eliminating their dependency on fossil fuels. The company innovates and industrializes electrification and carbon separation technologies targeting hard-to-abate sectors like cement and quicklime. Its core technology is the Electric Arc Calciner (EAC), a proprietary electric calcination process that replaces fossil-fuel heating. The EAC technology simultaneously separates and captures process-related CO2 emissions, creating a pathway to zero-emission manufacturing. SaltX collaborates with major industrial partners, such as Holcim and SMA Mineral, to scale its solutions and achieve gigaton-level impact on global emissions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SaltX Technology Holding B filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SaltX Technology Holding B

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SaltX Technology Holding B via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Terns Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
United States of America
TERN
Tevogen Bio Holdings Inc. Logo
Developing precision, off-the-shelf T cell therapies for cancer, infections, and neuro disorders.
United States of America
TVGN
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom
TCF
Theriva Biologics, Inc. Logo
Develops systemic oncolytic virus therapies to selectively destroy difficult-to-treat cancers.
United States of America
TOVX
Thirdeye Systems Ltd. Logo
Develops AI-driven thermal/visual perception solutions for defense, security & autonomous systems.
Israel
THES
TiumBio Co., Ltd. Logo
Clinical-stage biopharma developing therapies for rare diseases, gynecology, and hemophilia.
South Korea
321550
Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden
TOL
ToolGen Incorporated Logo
A biotech firm licensing genome editing patents for therapeutics and agriculture.
South Korea
199800
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.